每年研究計畫
個人檔案
學歷
- 國立成功大學臨醫所博士
研究專長
- 血液疾病
- 腫瘤治療
- 腸胃道腫瘤治療
- 頭頸癌治療
指紋 查看啟用 Chia-Jui Yen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 74 類似的檔案
Hepatocellular Carcinoma
Medicine & Life Sciences
Head and Neck Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Hepatitis B virus
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Placebos
Medicine & Life Sciences
網絡
國家層面的近期外部合作。點選圓點深入探索詳細資料。
研究計畫 2004 2018
- 5 已完成
發展新穎分子抗癌藥物 (Integrins αvβ3, α5β1, and αvβ5-specific drugs)治療肝細胞癌臨床應用性探討
13-08-01 → 14-07-31
研究計畫: Research project
研究成果 2004 2019
4
引文
(Scopus)
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
Chou, W. C., Chen, J. S., Hung, C. Y., Lu, C. H., Shao, Y. Y., Chiou, T. J., Sung, Y. C., Rau, K. M., Yen, C-J., Yeh, S. P., Liu, T. C., Wu, M. F., Lee, M. Y., Yu, M. S., Hwang, W. L., Lai, P. Y., Chang, C. S. & Hsieh, R. K., 2019 八月 1, 於 : Supportive Care in Cancer. 27, 8, p. 2857-2867 11 p.研究成果: Article
Taiwan
Analgesics
Quality of Life
Neoplasms
Pain
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
Qin, S., Chan, S. L., Sukeepaisarnjaroen, W., Han, G., Choo, S. P., Sriuranpong, V., Pan, H., Yau, T., Guo, Y., Chen, M., Ren, Z., Xu, J., Yen, C. J., Lin, Z. Z., Manenti, L., Gu, Y., Sun, Y., Tiedt, R., Hao, L., Song, W. 及其他1, , 2019 一月 1, 於 : Therapeutic Advances in Medical Oncology. 11研究成果: Article
開啟存取
Hepatocellular Carcinoma
Safety
Logistic Models
Capsules
Pharmacokinetics
2
引文
(Scopus)
CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity
Chen, R. Y., Yen, C. J., Liu, Y. W., Guo, C. G., Weng, C. Y., Lai, C. H., Wang, Y. M., Lin, Y. J. & Hung, L. Y., 2019 一月 1, (Accepted/In press) 於 : Cell Death and Differentiation.研究成果: Article
Neoplasm Metastasis
Hepatocellular Carcinoma
Proteins
Interleukin-8
Interleukin-6
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Lu, L. C., Hsu, C., Shao, Y. Y., Chao, Y., Yen, C. J., Shih, I. L., Hung, Y. P., Chang, C. J., Shen, Y. C., Guo, J. C., Liu, T. H., Hsu, C. H. & Cheng, A. L., 2019 十一月 1, 於 : Liver Cancer. 8, 6, p. 480-490 11 p.研究成果: Article
開啟存取
Hepatocellular Carcinoma
Liver
Neoplasms
Lung
Monoclonal Antibodies
Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial
Yoshikawa, T., Muro, K., Shitara, K., Oh, D. Y., Kang, Y. K., Chung, H. C., Kudo, T., Chin, K., Kadowaki, S., Hamamoto, Y., Hironaka, S., Yoshida, K., Yen, C. J., Omuro, Y., Bai, L. Y., Maeda, K., Ozeki, A., Yoshikawa, R. & Kitagawa, Y., 2019 八月 2, 於 : JAMA network open. 2, 8, p. e198243研究成果: Article
開啟存取
oxaliplatin
Far East
Paclitaxel
Stomach Neoplasms
Randomized Controlled Trials
論文
The clinical significances and regulatory mechanisms of IGF2 mRNA-binding protein 3 (IGF2BP3) in hepatocellular carcinoma
作者: 彥妤, 劉., 2018 八月 15監督員: Yen, C. (Supervisor)
學生論文: Master's Thesis